CryoLife (NYSE: CRY) reported Q3 EPS of $0.13, $0.08 better than the analyst estimate of $0.05. Revenue for the quarter came in at $45.3 million versus the consensus estimate of $44.9 million.

GUIDANCE:

CryoLife sees FY2016 EPS of $0.43-$0.45, versus prior guidance of $0.32-$0.34. CryoLife sees FY2016 revenue of $181-182.5 million, versus prior guidance of $180-182 million.

For earnings history and earnings-related data on CryoLife (CRY) click here.